The actigraphy devices global market is projected to experience steady growth from $2.39 billion in 2024 to $2.61 billion in 2025, boasting a compound annual growth rate CAGR of 9.1%.

BOSTON, June 25, 2025--Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled EmbraceMini, its revolutionary new wearable for clinical ...

Empatica Unveils EmbraceMini: The World’s Smallest Actigraphy Wearable for Clinical Trials. Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI ...

At just 12mm thick and 14mm wide, EmbraceMini is the smallest wristworn actigraphy device for clinical research in the world – the size of an AA battery.

An actigraphy device is similar to a wristwatch and uses accelerometers to measure the person’s movement. Coupled with sleep diaries, actigraphy assumes a person is awake when they’re moving ...

Nachrichten » Empatica Unveils EmbraceMini: The World's Smallest Actigraphy Wearable for Clinical Trials. Push Mitteilungen. Business Wire. 25.06.2025 15:12 Uhr. 173 Leser. Artikel bewerten: (1) ...

Healthy sleep is often viewed as a matter of personal responsibility — setting a consistent bedtime, avoiding caffeine and limiting screen time before bed.

Dupilumab improved nasal polyp outcomes and asthma symptoms more than omalizumab in patients with CRSwNP and asthma, according to the head-to-head EVEREST phase 4 trial.

Participants had completed 7-day actigraphy monitoring with the Axivity AX3 model and had information within any mortality registry between 2013 and 2015.